Making it Work Program for Systemic Sclerosis

NCT ID: NCT06338722

Last Updated: 2025-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-08

Study Completion Date

2025-01-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical trial is to see if an online intervention program for people with Systemic Sclerosis (scleroderma) helps keep people in the workforce and increase self-confidence in dealing with challenges at work. The program is called Making it Work Systemic Sclerosis.

Researchers will compare a group who gets the program to a group who will get the program at a later point in time (wait list control group) to see if self-confidence in dealing with work challenge gets better.

People in the Making it Work group will complete questionnaires and attend one 2 hour meetings each week for 5 weeks and meet with an occupational therapist and vocational counselor. People in the wait list control group will complete the questionnaires and participate in the program at a later point in time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scleroderma, Systemic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Intervention receives the Making it work program Wait list Control receives usual care but will be offered the program after the intervention groups finish
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

People will know what group they are in when they are invited to attend the intervention sessions

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Complete questionnaires Attend one 2 hour weekly virtual meeting for 5 weeks and an individual meeting with an occupational therapist and with a vocational counselor

Group Type EXPERIMENTAL

Making it Work Systemic Sclerosis

Intervention Type OTHER

One 2 hour virtual meeting per week for 5 weeks, plus an individual meeting with an occupational therapist and a vocational counselor

control group

Complete questionnaires

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Making it Work Systemic Sclerosis

One 2 hour virtual meeting per week for 5 weeks, plus an individual meeting with an occupational therapist and a vocational counselor

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently employed (full-time, part-time)
* Over 18 and less than or equal to 67 years of age
* Reside and work in the United States
* Self-report diagnosis with systemic sclerosis (scleroderma; systemic sclerosis)
* Report concerns about risk for job loss
* Possess sufficient spoken English to participate in a group
* Have device with audio and visual videoconferencing capabilities
* Be willing to participate in a 2.0 hour virtual meeting once a week for 5 weeks
* Be willing to complete assigned pre-meeting worksheets
* Be willing to meet virtually with both an occupational therapist and vocational counselor after the 5th weekly sessin.

Exclusion Criteria

* Not working (full-time, part-time, self-employed, contract work)
* Pregnant
* Less than 18 and over 67 years of age
* Do not work in the United States
* Do not report are not concerned about job loss
* Do not have a device with audio and visual videoconferencing capabilities
* Do note communicate sufficiently in English
* Are not able to participate in the program for 5 weeks
* Are not wiling to complete pre-meeting worksheets
* Not willing to meet with both an occupational therapist and vocational counselor.
Minimum Eligible Age

18 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of New Mexico

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janet L Poole

Role: PRINCIPAL_INVESTIGATOR

University of New Mexico

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of New Mexico

Albuquerque, New Mexico, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-397

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Taking Charge of Systemic Sclerosis
NCT02494401 COMPLETED NA
Gut Microbiota Transplantation in Systemic Sclerosis
NCT03444220 COMPLETED PHASE1/PHASE2
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992 ACTIVE_NOT_RECRUITING NA
Fresolimumab In Systemic Sclerosis
NCT01284322 COMPLETED PHASE1